- Home
- OTLK vs NVA Comparison
OTLK vs NVA Comparison
Compare OTLK & NVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- NVA
- Stock Information
- Founded
- OTLK 2010
- NVA 1987
- Country
- OTLK United States
- NVA Australia
- Employees
- OTLK N/A
- NVA N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- NVA
- Sector
- OTLK Health Care
- NVA
- Exchange
- OTLK Nasdaq
- NVA NYSE
- Market Cap
- OTLK 64.6M
- NVA 62.5M
- IPO Year
- OTLK 2016
- NVA N/A
- Fundamental
- Price
- OTLK $1.83
- NVA $10.58
- Analyst Decision
- OTLK Strong Buy
- NVA
- Analyst Count
- OTLK 5
- NVA 0
- Target Price
- OTLK $21.00
- NVA N/A
- AVG Volume (30 Days)
- OTLK 892.5K
- NVA 58.0K
- Earning Date
- OTLK 02-12-2025
- NVA 01-01-0001
- Dividend Yield
- OTLK N/A
- NVA N/A
- EPS Growth
- OTLK N/A
- NVA N/A
- EPS
- OTLK N/A
- NVA N/A
- Revenue
- OTLK N/A
- NVA N/A
- Revenue This Year
- OTLK N/A
- NVA N/A
- Revenue Next Year
- OTLK $396.84
- NVA N/A
- P/E Ratio
- OTLK N/A
- NVA N/A
- Revenue Growth
- OTLK N/A
- NVA N/A
- 52 Week Low
- OTLK $0.87
- NVA $4.35
- 52 Week High
- OTLK $12.85
- NVA $19.00
- Technical
- Relative Strength Index (RSI)
- OTLK 39.18
- NVA N/A
- Support Level
- OTLK $1.79
- NVA N/A
- Resistance Level
- OTLK $2.26
- NVA N/A
- Average True Range (ATR)
- OTLK 0.18
- NVA 0.00
- MACD
- OTLK 0.00
- NVA 0.00
- Stochastic Oscillator
- OTLK 6.09
- NVA 0.00
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About NVA NOVA MINERALS LTD SPON ADS EACH REP 60 ORD
Nova Minerals Ltd is a Gold, Antimony and Critical Minerals exploration and development company focused on advancing the Estelle Project. It includes projects such as Estelle Gold and Critical Minerals Project, RPM, Korbel, Train and Stoney. It operates in one segment which is exploration of minerals and two geographical areas, being Australia and United States, where Australia derives maximum revenue.